Regulatory Strategy in The Pharmaceutical Industry: Paving the Way From Concept to Commercialization

Regulatory strategy in the pharmaceutical industry refers to the plan put in place by a pharmaceutical company to ensure compliance with laws, regulations, and guidelines set forth by regulatory agencies such as the Food and Drug Administration (FDA) in the United States or the European Medicines Agency (EMA) in Europe or any other relevant drug regulatory authorities.

Some key components of a successful regulatory strategy in the pharmaceutical industry include:

  • Understanding and staying up-to-date with the relevant regulatory requirements and guidelines in the markets where the company operates.
  • Planning and conducting comprehensive technical studies to generate the data needed to support regulatory submissions for drug approvals.
  • Developing strong relationships with regulatory agencies to facilitate communication and collaboration throughout the drug development process.
  • Establishing effective processes and systems for managing regulatory submissions, approvals, and compliance activities.
  • Ensuring that all manufacturing and quality control processes meet regulatory standards to ensure the safety, efficacy, and quality of the company's products.
  • Anticipating and preparing for potential regulatory challenges and changes that may impact the company's business operations.

Overall, a well-defined regulatory strategy is essential for pharmaceutical companies to successfully navigate the complex and highly regulated environment of the industry. It helps ensure that products are developed, manufactured, and marketed in compliance with all relevant regulations, ultimately leading to the successful commercialization of safe and effective medicines.

Webinar Jan 01 2026, Thursday 01:00 PM EDT 60 Minutes Intermediate Level Code: GRC0000274

  • What is a regulatory strategy?
  • Importance of regulatory strategy for pharmaceutical companies
  • Principles of regulatory strategy development and implementation.
  • Key components of the regulatory strategy
  • Building strategy workflow

  • Regulatory affairs professionals in the pharmaceutical industry
  • Business development professionals in the pharmaceutical industry.

  •  How to develop a regulatory strategy for products in various stages of the product life cycle?
  • How to analyze the strengths and weaknesses of a product in order to develop regulatory strategies and target product profiles?
  • How to use best practices when communicating a regulatory strategy to the company project team or top management?
  • Companies that have a strong regulatory strategy in place are better positioned to bring products to market quickly and efficiently.
  • Understanding regulatory requirements can help streamline the product development and approval process, saving time and resources.
  • By learning how to develop a regulatory strategy early on in the product development process, you can avoid common pitfalls and delays.

MOHAMMAD ELNADI
MOHAMMAD ELNADI
20 Years

Mohammad is a highly accomplished pharmaceutical professional with over 20 years of experience in the pharmaceutical industry, specializing in business development, regulatory affairs, supply chain management, and international training. As a co-founder of the Arab Pharma Experts Association (APEA), Mohammad has established himself as a trusted expert in the field, combining his deep regulatory knowledge with strong business acumen to drive success in both local and international markets.
Mohammad began his career after earning a bachelor’s degree in Pharmaceutical Science from the University of Cairo in 2005. He quickly gained hands-on experience in research and development (R&D) and production of pharmaceutical dosage forms, as well as in coordinating contract manufacturing activities. His passion for continuous learning led him to pursue a postgraduate certificate in management from the American University in Cairo (AUC), where he honed his skills in marketing, project management, finance, and organizational behavior. Over the years, Mohammad has held several senior management roles, including Business Development Senior Officer, Supply Chain Manager, and Product development project manager at Elrazy Pharmaceuticals Co. In these positions, he successfully led market access projects, negotiated deals with overseas agents, and established supply chain strategies that aligned with the company’s overall goals. His efforts have enabled Elrazy Pharmaceuticals to expand its presence in key markets across Africa, ASEAN, and the GCC regions.In addition to his corporate roles, Mohammad has served as an independent pharmaceutical consultant and trainer, working with organizations such as IPI Academy in London and Pharmastate Academy in Delhi. He has delivered a wide range of training courses on topics such as Regulatory landscape, regulatory project management, supply chain optimization, and risk management. His expertise has benefited professionals from leading pharmaceutical companies across Egypt, UAE, KSA, Sudan, Spain, Portugal, Sweden & beyond.Mohammad’s extensive experience also includes roles as Managing Director of REYADA PRO for pharmaceutical services and consultancy, where he provided strategic guidance to clients, and as Regulatory Business Development Manager at REG EXPERTS, where he helped companies navigate complex regulatory landscapes. His ability to bridge the gap between regulatory compliance and business strategy has made him a sought-after expert in the industry. As an international trainer, Mohammad has conducted numerous online and offline courses, sharing his knowledge with professionals from diverse geographical regions. His training programs cover critical areas such as MENA region guidelines for drug registration, pharmaceutical supply chain management, and product development. His practical approach and real-world insights have earned him a reputation as a dynamic and engaging trainer. Mohammad’s educational background is complemented by a wide range of professional certifications, including Lean Green Belt, QMS Lead Auditor ISO 9001, and a Data Analytics Nanodegree from Udacity. He is also a certified business analyst and has completed advanced courses in strategic marketing, communication skills, and problem-solving. With a proven track record of driving cost efficiency, regulatory compliance, and market expansion, Mohammad continues to make significant contributions to the pharmaceutical industry. His unique blend of regulatory expertise, business development skills, and training capabilities positions him as a key player in shaping the future of pharmaceutical manufacturing and supply chain management.

  • 60 Mins | Nov 04, Tue , 01:00 PM EDT

The price of medicines is one of the factors that can limit the affordability of medicines to the population.  So...

MOHAMMAD ELNADI By MOHAMMAD ELNADI

  • 60 Mins | Jan 01, Thu , 01:00 PM EDT

Counterfeit drugs pose a public health hazard, waste consumer income, and reduce the incentive to engage in research and...

MOHAMMAD ELNADI By MOHAMMAD ELNADI

  • 60 Mins | Jan 01, Thu , 01:00 PM EDT

The price of medicines is one of the factors that can limit the affordability of medicines to the population. So there...

MOHAMMAD ELNADI By MOHAMMAD ELNADI

  • Oct 27, Monday | 01:00 PM EDT | 75 Mins

Tattoos were always associated with sailors, marines, and bikers. Not today. Over the past few decades, there has been r...

  • Oct 27, Monday | 01:00 PM EDT | 60 Mins

This webinar is for you if you ever find yourself in a difficult emotional situation where a cool head is necessary. Th...

  • Oct 27, Monday | 08:12 PM EDT | 90 Mins

Nisi earum est dicta ab perspiciatis expedita sint. Sint voluptatem deserunt autem rerum quia possimus ea asperiores. Fa...

By